These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 14499683)
1. Prospective study on the efficacy of a selective treatment and risk factors for relapse in recurrent calcium oxalate stone patients. Siener R; Glatz S; Nicolay C; Hesse A Eur Urol; 2003 Oct; 44(4):467-74. PubMed ID: 14499683 [TBL] [Abstract][Full Text] [Related]
2. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients. Siener R; Schade N; Nicolay C; von Unruh GE; Hesse A J Urol; 2005 May; 173(5):1601-5. PubMed ID: 15821507 [TBL] [Abstract][Full Text] [Related]
3. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group. Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F; Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027 [TBL] [Abstract][Full Text] [Related]
5. The role of overweight and obesity in calcium oxalate stone formation. Siener R; Glatz S; Nicolay C; Hesse A Obes Res; 2004 Jan; 12(1):106-13. PubMed ID: 14742848 [TBL] [Abstract][Full Text] [Related]
6. Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines. Skolarikos A; Straub M; Knoll T; Sarica K; Seitz C; Petřík A; Türk C Eur Urol; 2015 Apr; 67(4):750-63. PubMed ID: 25454613 [TBL] [Abstract][Full Text] [Related]
7. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. Borghi L; Meschi T; Amato F; Briganti A; Novarini A; Giannini A J Urol; 1996 Mar; 155(3):839-43. PubMed ID: 8583588 [TBL] [Abstract][Full Text] [Related]
8. [Mineralogical composition of urinary stones, risk factors and metabolic disturbances in patients with calcium-oxalate urolithiasis]. Kustov AV; Strelnikov AI; Moryganov MA; Airapetyan AO; Smirnov PR; Lyalyakina EV; Toms SR Urologiia; 2017 Sep; (4):22-26. PubMed ID: 28952687 [TBL] [Abstract][Full Text] [Related]
9. Short-Term Changes in Urinary Relative Supersaturation Predict Recurrence of Kidney Stones: A Tool to Guide Preventive Measures in Urolithiasis. Ferraro PM; Ticinesi A; Meschi T; Rodgers A; Di Maio F; Fulignati P; Borghi L; Gambaro G J Urol; 2018 Nov; 200(5):1082-1087. PubMed ID: 29940247 [TBL] [Abstract][Full Text] [Related]
10. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation. Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919 [TBL] [Abstract][Full Text] [Related]
11. The effects of a single evening dose of alkaline citrate on urine composition and calcium stone formation. Berg C; Larsson L; Tiselius HG J Urol; 1992 Sep; 148(3 Pt 2):979-85. PubMed ID: 1507355 [TBL] [Abstract][Full Text] [Related]
12. Factors influencing the course of calcium oxalate stone disease. Tiselius HG Eur Urol; 1999 Nov; 36(5):363-70. PubMed ID: 10516443 [TBL] [Abstract][Full Text] [Related]
13. [Clinical studies of the recurrence of urolithiasis (4). Crystal formation in urine and stone recurrence]. Murayama T; Taguchi H Hinyokika Kiyo; 1988 Sep; 34(9):1543-7. PubMed ID: 3213790 [TBL] [Abstract][Full Text] [Related]
14. Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference? Tefekli A; Esen T; Ziylan O; Erol B; Armagan A; Ander H; Akinci M Urol Int; 2003; 70(4):273-7. PubMed ID: 12740490 [TBL] [Abstract][Full Text] [Related]
15. Stone recurrence predictive score (SRPS) for patients with calcium oxalate stones. Lee YH; Huang WC; Lu CM; Tsai JY; Huang JK J Urol; 2003 Aug; 170(2 Pt 1):404-7. PubMed ID: 12853786 [TBL] [Abstract][Full Text] [Related]
16. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi]. Hess B Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986 [TBL] [Abstract][Full Text] [Related]
17. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers. Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490 [TBL] [Abstract][Full Text] [Related]
18. The urinary response to an oral oxalate load in recurrent calcium stone formers. Krishnamurthy MS; Hruska KA; Chandhoke PS J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711 [TBL] [Abstract][Full Text] [Related]
19. Effect of potassium citrate therapy on stone recurrence and residual fragments after shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: a randomized controlled trial. Soygür T; Akbay A; Küpeli S J Endourol; 2002 Apr; 16(3):149-52. PubMed ID: 12028622 [TBL] [Abstract][Full Text] [Related]
20. [Effects of urinary pH and acid-base balance on the formation of calcium oxalate stone]. Iida S Nihon Hinyokika Gakkai Zasshi; 1991 Jan; 82(1):33-40. PubMed ID: 2046198 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]